Mark B. Meads

β1 Integrin Adhesion Enhances IL-6–Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation

Kenneth H. Shain, Danielle N. Yarde, Mark B. Meads et al. · Cancer Research · 2009 · 198 citations · Full text

Inflammation, Cytokine, Fn Adhesion +15

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma

Xiaohong Zhao, Tint Lwin, Ariosto Silva et al. · Nature Communications · 2017 · 147 citations · Full text

XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma

Joel G. Turner, Trinayan Kashyap, Jana L. Dawson et al. · Oncotarget · 2016 · 88 citations · Full text

Hematological Malignancy, Tumor Biology, Proteasome Inhibitor Resistance +13

Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors

Joel G. Turner, Jana L. Dawson, Steven Grant et al. · Journal of Hematology & Oncology · 2016 · 81 citations · Full text

BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models

Xiaohong Zhao, Yuan Ren, Matthew A. Lawlor et al. · Cancer Cell · 2019 · 80 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Abt-199 Resistance +10